Streetbeat News

Price Targets

GL

In the past three months, 10 analysts have provided ratings for Globe Life (NYSE:GL), showing a range of perspectives from bullish to bearish. Recently, analysts have lowered their price targets, with the average target now at $112.5, down 15.35%. Key analysts from firms like Wells Fargo, Keefe, Bruyette & Woods, and Piper Sandler have all lowered their ratings and price targets. Despite strong net margins and ROA, Globe Life's ROE is below industry standards.

Portfolio Pulse from Benzinga Insights

May 21, 2024 | 6:00 pm

CAVA

Citigroup analyst Jon Tower maintains a Neutral rating on Cava Group (NYSE:CAVA) and raises the price target from $60 to $81.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 5:56 pm

PANW

Macquarie analyst Sarah Hindlian maintains a Neutral rating on Palo Alto Networks (NASDAQ:PANW) and raises the price target from $270 to $285.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 5:35 pm

TYL

Loop Capital has maintained its Buy rating on Tyler Technologies (NYSE:TYL) and raised the price target from $485 to $530.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 5:32 pm

SNDX

JP Morgan analyst Anupam Rama maintains an Overweight rating on Syndax Pharmaceuticals (NASDAQ:SNDX) with a $34 price target.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 5:27 pm

PANW

Morgan Stanley analyst Hamza Fodderwala has reiterated an Overweight rating on Palo Alto Networks (NASDAQ:PANW) and maintained a price target of $360.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 5:25 pm

LI

Morgan Stanley maintains an Overweight rating on Li Auto but lowers the price target from $65 to $53.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 5:21 pm

BE

RBC Capital analyst Chris Dendrinos has reiterated an Outperform rating on Bloom Energy (NYSE:BE) and maintained a $14 price target.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 5:19 pm

HOOK

RBC Capital analyst Brian Abrahams has reiterated an Outperform rating on HOOKIPA Pharma (NASDAQ:HOOK) and maintained a $5 price target.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 5:10 pm

NEXN

RBC Capital analyst Matthew Swanson has reiterated an Outperform rating on Nexxen International (NASDAQ:NEXN) and maintained a price target of $8.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 5:08 pm